JPS58216050A - 骨組織欠損の一時的代用組成物 - Google Patents
骨組織欠損の一時的代用組成物Info
- Publication number
- JPS58216050A JPS58216050A JP57098610A JP9861082A JPS58216050A JP S58216050 A JPS58216050 A JP S58216050A JP 57098610 A JP57098610 A JP 57098610A JP 9861082 A JP9861082 A JP 9861082A JP S58216050 A JPS58216050 A JP S58216050A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- bone
- cyanacrylate
- composition according
- bone tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims description 68
- 210000000988 bone and bone Anatomy 0.000 title claims description 55
- -1 acrylic ester Chemical class 0.000 claims description 16
- 230000007547 defect Effects 0.000 claims description 13
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- 159000000007 calcium salts Chemical class 0.000 claims description 12
- IJVRPNIWWODHHA-UHFFFAOYSA-N 2-cyanoprop-2-enoic acid Chemical compound OC(=O)C(=C)C#N IJVRPNIWWODHHA-UHFFFAOYSA-N 0.000 claims description 10
- 239000000945 filler Substances 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 230000008929 regeneration Effects 0.000 claims description 8
- 238000011069 regeneration method Methods 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims 1
- 239000002269 analeptic agent Substances 0.000 claims 1
- 229940050410 gluconate Drugs 0.000 claims 1
- 239000004615 ingredient Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 229960004494 calcium gluconate Drugs 0.000 description 8
- 239000004227 calcium gluconate Substances 0.000 description 8
- 235000013927 calcium gluconate Nutrition 0.000 description 8
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 8
- 238000005452 bending Methods 0.000 description 6
- 238000006065 biodegradation reaction Methods 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 206010031252 Osteomyelitis Diseases 0.000 description 4
- 230000004580 weight loss Effects 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 235000011148 calcium chloride Nutrition 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 239000000021 stimulant Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- WCHFOOKTKZYYAE-UHFFFAOYSA-N ethoxyperoxyethane Chemical compound CCOOOCC WCHFOOKTKZYYAE-UHFFFAOYSA-N 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- IQDPHMACOQAPBQ-UHFFFAOYSA-N 2-ethoxyethyl 2-cyanoprop-2-enoate Chemical compound CCOCCOC(=O)C(=C)C#N IQDPHMACOQAPBQ-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 206010031256 Osteomyelitis chronic Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000028347 Sinus disease Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Natural products O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 1
- 241001400064 Valeria Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 208000024035 chronic otitis media Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000001180 ethmoid sinus Anatomy 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 1
- 210000002082 fibula Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000004086 maxillary sinus Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000022949 middle ear disease Diseases 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 208000008798 osteoma Diseases 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011470 radical surgery Methods 0.000 description 1
- 238000002278 reconstructive surgery Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- ZXYAAVBXHKCJJB-UHFFFAOYSA-N uracil-5-carboxylic acid Chemical class OC(=O)C1=CNC(=O)NC1=O ZXYAAVBXHKCJJB-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57098610A JPS58216050A (ja) | 1982-06-10 | 1982-06-10 | 骨組織欠損の一時的代用組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57098610A JPS58216050A (ja) | 1982-06-10 | 1982-06-10 | 骨組織欠損の一時的代用組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58216050A true JPS58216050A (ja) | 1983-12-15 |
| JPS6118462B2 JPS6118462B2 (enrdf_load_stackoverflow) | 1986-05-13 |
Family
ID=14224356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57098610A Granted JPS58216050A (ja) | 1982-06-10 | 1982-06-10 | 骨組織欠損の一時的代用組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58216050A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6168054A (ja) * | 1984-09-10 | 1986-04-08 | 増原 英一 | 人工骨及び人工歯 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6399163U (enrdf_load_stackoverflow) * | 1987-12-10 | 1988-06-27 | ||
| JPH01189461A (ja) * | 1988-01-25 | 1989-07-28 | Matsushita Electric Ind Co Ltd | 温風暖房器 |
-
1982
- 1982-06-10 JP JP57098610A patent/JPS58216050A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6168054A (ja) * | 1984-09-10 | 1986-04-08 | 増原 英一 | 人工骨及び人工歯 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6118462B2 (enrdf_load_stackoverflow) | 1986-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6593394B1 (en) | Bioactive and osteoporotic bone cement | |
| JP3559565B2 (ja) | 生体材料用組成物及びその製造法 | |
| JP6989148B2 (ja) | 注射用の生分解性骨セメントとそれを作製及び使用する方法 | |
| Takagi et al. | Properties of elastomeric calcium phosphate cement–chitosan composites | |
| JP5753336B2 (ja) | リン酸カルシウムセメントおよびそれを使用する方法 | |
| Hu et al. | A mechanically reinforced super bone glue makes a leap in hard tissue strong adhesion and augmented bone regeneration | |
| JP5323354B2 (ja) | 多目的生体材料組成物 | |
| RU2407552C2 (ru) | Инъецируемый композитный материал, пригодный для использования в качестве заменителя костной ткани | |
| US4407793A (en) | Composition for temporary substitution of bone tissue defects | |
| CN1307908A (zh) | 无机骨粘合剂及其在人体硬组织修复中的应用 | |
| CN114917397B (zh) | 一种骨粘合剂的固相组合物及骨粘合剂 | |
| Senthil et al. | Nano apatite growth on demineralized bone matrix capped with curcumin and silver nanoparticles: Dental implant mechanical stability and optimal cell growth analysis | |
| Holt et al. | Leakage of amalgam, composite, and Super-EBA, compared with a new retrofill material: bone cement | |
| JPS62503148A (ja) | 骨セメント | |
| JP2020508721A (ja) | インスタントナノ多孔性バイオ人工骨組織合成物エンジニアリングの方法 | |
| US5980625A (en) | Calcium phosphate composition and a setting solution therefor | |
| Gosain et al. | The current status of tissue glues: I. For bone fixation | |
| JPS58216050A (ja) | 骨組織欠損の一時的代用組成物 | |
| WO2024133597A1 (en) | Bioadhesive composition | |
| CN115554468A (zh) | 含生物活性玻璃的骨水泥及其制备方法和应用 | |
| Al-Shamaa et al. | Remineralizing capacity of zinc oxide eugenol sealer following the addition of nanohydroxyapatite-tyrosine amino acid: An in vivo animal study | |
| RU2508131C2 (ru) | Отверждаемый биокомпозиционный материал для замещения костных дефектов | |
| Heilig et al. | A magnesium calcium phosphate-based cement as a bone adhesive: characterization and biomechanical evaluation | |
| JP2015514535A5 (enrdf_load_stackoverflow) | ||
| GB2121067A (en) | Polymerizable composition for temporary substitution of bone tissue defects |